Transglutaminase 3 expression in hepatocellular carcinoma patients: Correlation with tumor features and survival profile
{{output}}
Background: Transglutaminase 3 (TGM3) regulates multiple oncogene pathways (GSK-3β/β-catenin pathway, Akt/ERK pathway, etc.) to promote hepatocellular carcinoma (HCC) cell proliferation, migration and invasion, however, its cli... ...
